Skip to main content
. 2023 Aug 4;8(4):550–561. doi: 10.1016/j.ncrna.2023.08.001

Table 1.

Clinical features of LSCC patients in TCGA and Shanxi cohorts.

Parameters Number of Cases
TCGA cohort Shanxi cohort
Gender
Male 97 (82.91%) 100 (93.46%)
Female 20 (17.09%) 7 (6.54%)
Age(Years)
≤60 49 (41.88%) 56 (52.34%)
>60 68 (58.12%) 51 (47.66%)
Vital Status
Alive 67 (57.26%) 62 (57.94%)
Dead 50 (42.74%) 17 (15.89%)
Unknown 0 (0.00%) 28 (26.17%)
Pathologic T Stage
T1 7 (5.98%) 30 (28.04%)
T2 14 (11.97%) 28 (26.17%)
T3 26 (22.22%) 28 (26.17%)
T4 55 (47.01%) 21 (19.62%)
TX 13 (11.11%) 0 (0.00%)
Unknown 2 (1.71%) 0 (0.00%)
Clinical N Stage
N0 56 (47.86%) 80 (74.78%)
N+ 55 (47.01%) 27 (25.22%)
NX 5 (4.27%) 0 (0.00%)
Unknown 1 (0.86%) 0 (0.00%)
Clinical Stage
Stage I 3 (2.56%) 29 (27.10%)
Stage II 12 (10.26%) 24 (22.43%)
Stage III 27 (23.08%) 24 (22.43%)
Stage IV 71 (60.68%) 30 (28.04%)
Unknown 4 (3.42%) 0 (0.00%)
Alcohol History
Yes 76 (64.96%) 32 (29.91%)
No 39 (33.33%) 75 (70.09%)
Unknown 2 (1.71%) 0 (0.00%)
Cigarettes History
Yes 80 (68.38%) 92 (85.98%)
No 37 (31.62%) 15 (14.02%)